| Literature DB >> 30062489 |
Lei Li1, Hiroshi Hasegawa2, Niro Inaba3, Wataru Yoshioka4, Dennis Chang5, JianXun Liu1, Kimiyoshi Ichida6.
Abstract
Plasma homocysteine is elevated in patients with impaired renal function, and markedly so at end-stage renal disease. As chronic kidney disease and hyperhomocysteinemia are also independent risk factors for cardiovascular disease, the latter is hypothesized to accelerate vascular abnormalities following renal failure. This study aimed to investigate the combined effect of impaired renal function and hyperhomocysteinemia on vascular function. We show that in 5/6-nephrectomized rats, a model of chronic kidney disease, a methionine-rich diet for 8 weeks induces moderate hyperhomocysteinemia, exacerbates hypertension, and attenuates the vascular response to acetylcholine, sodium nitroprusside, 8-bromo-cGMP, and isoprenaline. However, plasma nitrate/nitrite and total NOS activity in the thoracic aorta were not affected. Collectively, the data imply that hyperhomocysteinemia and end-stage renal disease synergistically impair endothelium-dependent and endothelium-independent vasodilatation by blocking the cGMP/protein kinase G and/or cAMP/protein kinase A pathways. 5/6-Nephrectomized rat with hyperhomocysteinemia induced by a methionine-rich diet would be a useful model for elucidating the pathogenesis of vascular impairment in patients with end-stage renal disease.Entities:
Keywords: 5/6 nephrectomy; Chronic kidney disease; Homocysteine; Hyperhomocysteinemia; Vasodilatation
Mesh:
Substances:
Year: 2018 PMID: 30062489 DOI: 10.1007/s00726-018-2626-3
Source DB: PubMed Journal: Amino Acids ISSN: 0939-4451 Impact factor: 3.520